Comparison

SkQ1 vs C60 Fullerene

Targeted mitochondrial antioxidant (SkQ1) vs. broad-spectrum radical sponge (C60 fullerene).

Effectiveness Profile

SkQ1
C60 Fullerene

At a Glance

 SkQ1C60 Fullerene
TypeLongevityLongevity
Legal statusResearchResearch
Half-lifeUnknown in humans~7HR (plasma, oral olive-oil)
Preferred routeOralOral
Dose frequencyonce-dailyonce-daily
Beginner dose125–250 mcg4–8 mg
Intermediate dose250–250 mcg10–15 mg
Advanced dose250–500 mcg20–35 mg
Cycle length12–52 wks4–52 wks
Active duration24h—
StorageRoom tempRoom temp
PCT requiredNoNo
Ancillaries requiredNoNo
Safe for womenYesYes

Verdict

SkQ1 wins for:

  • Precision mitochondrial targeting: SkQ1's triphenylphosphonium (TPP+) carrier drives it inside mitochondria, interrupting cardiolipin peroxidation at the source, with orders-of-magnitude higher intramitochondrial concentrations versus generic antioxidants.
  • Clinical validation: Only mito-antioxidant with phase 3 RCT data (Visomitin) and clean animal lifespan extension record across multiple species.
  • Predictable low dosing: Nanomolar-range protocols (100–500 µg/day); bell-shaped dose-response curve is well-mapped.

C60 Fullerene wins for:

  • Raw free-radical scavenging capacity: Each C60 molecule neutralizes dozens of reactive species without being consumed, acting catalytically in tissues.
  • Broader system-wide effects: Nrf2 pathway activation and upregulation of endogenous antioxidant enzymes (SOD, catalase, glutathione).
  • Greater flexibility: Bulk oral and topical approaches; not limited to mitochondrial antioxidant applications. Sourcing is more widespread, with wide community adoption.
  • Fatigue resistance/recovery in some animal models.

Pick A or B?

Pick SkQ1 if:

  • Targeted mitochondrial membrane protection is the main goal (e.g. supporting tissues exposed to high oxidative load on cycles, supporting cardiac or hepatic recovery, looksmaxxing longevity stacks).
  • Dry-eye management or retinoid-induced eye issues are present (ophthalmic forms, e.g. Visomitin).
  • Stack requires tight control of dosing and a clean, bell-shaped response curve.
  • Preference for a compound with clinical validation, proven safety, and traceable manufacturer.

Pick C60 Fullerene if:

  • Seeking broad-spectrum antioxidant and Nrf2 upregulation effects rather than mitochondrial targeting alone.
  • Hepatoprotection is needed on harsh oral cycles and a broad safety net is valuable.
  • Experimenting with fatigue reduction, recovery support, or general oxidative stress lowering (especially in older or high-volume training protocols).
  • Bulk sourcing, price, or topical protocol flexibility matter more than pinpoint mitochondrial action.
  • Willing to invest in high-purity, solvent-free C60 sourcing (quality tolerance is essential for this compound).

Where to Buy

Swiss Chems

Swiss Chems

Ships from USWidest catalogCapsules, powders & injectables

Affiliate link — we may earn a commission at no cost to you.

10% off — auto-applied at checkout